If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

Related content
Volume 5, Number 3, June 2006

< previous issue | all issues | next issue >

Articles

Favourites:Add to Favourites

G Protein-Coupled Receptors in Regulation of Body Weight
pp. 241-249(9)
Author: Schioth, Helgi B.

Favourites:Add to Favourites

Melanocortin Receptors as Drug Targets for Disorders of Energy Balance
pp. 251-261(11)
Authors: Adan, Roger A.H; Dijk, Gertjan v.

Favourites:Add to Favourites

NPY Receptors as Drug Targets for the Central Regulation of Body Weight
pp. 263-274(12)
Authors: Feletou, Michel; Galizzi, Jean-Pierre; Levens, Nigel R.

Favourites:Add to Favourites

Endocannabinoids in Appetite Control and the Treatment of Obesity
pp. 275-292(18)
Authors: Kirkham, T. C.; Tucci, S. A.

Favourites:Add to Favourites

Monoamine Receptors in the Regulation of Feeding Behaviour and Energy Balance
pp. 293-312(20)
Authors: Clifton, P. G.; Kennett, G. A.

Favourites:Add to Favourites

Galanin/GALP Receptors and CNS Homeostatic Processes
pp. 327-334(8)
Authors: Robinson, J. K.; Bartfai, T.; Langel, U.

Favourites:Add to Favourites

Growth Hormone Secretagogue (Ghrelin-) Receptors - A Complex Drug Target for the Regulation of Body Weight
pp. 335-343(9)
Authors: Nogueiras, R.; Perez-Tilve, D.; Wortley, K. E.; Tschop, M.

Favourites:Add to Favourites

D1 and Functionally Selective Dopamine Agonists as Neuroprotective Agents in Parkinson's Disease
pp. 345-353(9)
Authors: Lewis, M. M.; Huang, X.; Nichols, D. E.; Mailman, R. B.

Favourites:Add to Favourites

Signaling Mechanisms Underlying Aβ Toxicity: Potential Therapeutic Targets for Alzheimer's Disease
pp. 355-361(7)
Authors: Smith, Wanli W.; Gorospe, Myriam; Kusiak, John W.

Favourites:Add to Favourites

The Vitamin D Neuroendocrine System as a Target for Novel Neurotropic Drugs
pp. 363-371(9)
Authors: Kalueff, A. V.; Minasyan, A.; Keisala, T.; Kuuslahti, M.; Miettinen, S.; Tuohimaa, P.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more